期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Meiotic nuclear divisions 1 suppresses the proliferation and invasion of pancreatic cancer cells via regulating H2A.X variant histone
1
作者 DONGQIN WANG YAN SHI +8 位作者 ZHIQIANG WANG JING ZHANG LUYAO WANG HONGYU MA SHUHUA SHI XIAOFU LIAN HUA HUANG XIAOJING WANG CHAOQUN LIAN 《BIOCELL》 SCIE 2024年第1期111-122,共12页
Introduction:Among all malignant tumors of the digestive system,pancreatic carcinoma exhibits the highest mortality rate.Currently,prevention and effective treatment are urgent issues that need to be addressed.Methods... Introduction:Among all malignant tumors of the digestive system,pancreatic carcinoma exhibits the highest mortality rate.Currently,prevention and effective treatment are urgent issues that need to be addressed.Methods:The study focused on meiotic nuclear divisions 1(MND1),integrating data from the Gene Expression Profiling Interactive Analysis(GEPIA)database with prognostic survival analysis.Simultaneously,experiments at cellular level were employed to demonstrate the effect of MND1 on the proliferation and migration of PC.The small-molecule inhibitor of MND1 was used to suppress the migration of PC cells by knocking down MND1 using small interfering RNA(siRNA)in Patu-8988 and Panc1 cell lines.Results:The results of Cell Counting Kit-8 indicated that the suppression of MND1 resulted in a decrease in cell proliferation.Wound healing and Transwell assays revealed that MND1 knockdown reduced cell migration and invasion.Flow cytometry revealed that inhibiting MND1 hindered the cell cycle.Furthermore,MND1 could stimulate the proliferation,migration,and invasion of Patu-8988 and Panc1 cells by increasing the expression of MND1.Notably,MND1 had a positive effect on H2AFX expression in PC cells.Elevated MND1 expression suggests the low overall survival rate of individuals diagnosed with PC.Conclusion:These findings suggest that MND1 has the potential to be a gene with the ability to accurately diagnose and treat PC. 展开更多
关键词 Pancreatic carcinoma MND1 h2afx Cell cycle
下载PDF
H2AFX基因在肺腺癌中的表达及对预后的影响
2
作者 曹灵杰 郭宇杰 +3 位作者 李沛泉 甄妍 王润阳 魏佳庆 《华西医学》 CAS 2022年第2期224-230,共7页
目的探索H2A组蛋白家族成员X(H2A histone family,member X,H2AFX)基因在肺腺癌中的表达及对预后的影响。方法通过挖掘肿瘤基因组图谱数据库,分析H2AFX基因在肺腺癌患者肿瘤组织(497例)和癌旁正常组织(54例)中的表达情况。根据H2AFX在... 目的探索H2A组蛋白家族成员X(H2A histone family,member X,H2AFX)基因在肺腺癌中的表达及对预后的影响。方法通过挖掘肿瘤基因组图谱数据库,分析H2AFX基因在肺腺癌患者肿瘤组织(497例)和癌旁正常组织(54例)中的表达情况。根据H2AFX在肺腺癌样本中表达水平,将肺腺癌患者划分为高表达、低表达两组,使用logistic回归分析H2AFX与患者的临床病理特征关系。利用Kaplan-Meier法和对数秩检验分析H2AFX表达和肺腺癌患者预后的相关性,使用单因素和多因素Cox回归分析其预后价值。利用基因集富集分析方法分析H2AFX在肺腺癌发生发展中相关的基因通路。结果H2AFX基因在肺腺癌组织中表达高于正常组织(P<0.001),且与患者的年龄(P<0.001)、T分期(P=0.007)、N分期(P=0.010)相关,而与M分期、性别无关(P>0.05)。Kaplan-Meier法和对数秩检验分析显示,肺腺癌患者中,H2AFX基因高表达组患者生存率低于低表达组患者(P<0.001);多因素Cox回归分析结果显示,H2AFX可以作为肺腺癌的独立预后因子[风险比=1.41,95%置信区间(1.11,1.78),P=0.004]。基因集富集分析结果显示,H2AFX参与了细胞周期、同源重组、DNA复制、碱基切除修复、剪切体、错配修复、p53信号通路、核苷酸切除修复、RNA降解、RNA聚合酶等通路。结论H2AFX基因在肺腺癌中高表达,与肺腺癌预后以及发生发展密切相关。该基因有望成为肺腺癌新的分子标志物以及治疗的靶点之一。 展开更多
关键词 肺腺癌 h2afx基因 肿瘤基因组图谱数据库
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部